Class I · Recall · initiated February 13, 2026 · Terminated
Ambrosia Brands recalls 1.2 million bottles of Rosabella moringa capsules for Salmonella
A New York firm recalled 1,224,208 units of Rosabella brand moringa capsules for possible Salmonella, sold nationwide, in U.S. territories and to consumers in dozens of countries; the recall is now terminated.
The record
- Firm
- Ambrosia Brands LLC, New York, NY
- Product
- Rosabella brand MORINGA; DIETARY SUPPLEMENT CAPSULES; 60 capsules per bottle; Distributed by: Ambrosia Brands, LLC, 625 Randall Ave, St. 100, Cheyenne, WY 82001; SUGGESTED USE: As a dietary supplement, take two (2) veggie capsules once a day. For best results, take 20-30 min before a meal with an 8o
- Reason, as filed
- “Product may be contaminated with Salmonella”
- Classification
- Class I (Class I: reasonable probability of serious health consequences or death)
- Recall number
- H-0546-2026
- Initiated
- February 13, 2026
- Posted by FDA
- March 18, 2026
- Status
- Terminated · Voluntary: Firm initiated
- Quantity
- 1,224,208 units
- Distribution
- Nationwide in the United States, including American Samoa, Northern Mariana Islands, Puerto Rico, and Virgin Islands. International distribution to consumers in: Algeria, Anguilla, Australia, Austria, Bahrain, Belgium, Bosnia and Herzegovina, Brazil, Brunei, Bulgaria, Canada, Chile, Colombia, Croatia, Cyprus, Czech Republic, Denmark, Djibouti, Dominican Republic, Egypt, Estonia, Faroe Islands, Fi
Verify: search any recall number above in FDA's enforcement report database.
Why it happened, in plain English
The filed reason is “product may be contaminated with Salmonella.” The record does not say whether the firm found it, a customer did, or a regulator did, and it does not name a lot. The product is a single-ingredient moringa capsule, so the organism came in with the leaf powder. Moringa is a dried leaf. Drying preserves Salmonella rather than killing it, and encapsulation adds no kill step.
The scale is the unusual part: over 1.2 million units, shipped nationwide plus American Samoa, the Northern Mariana Islands, Puerto Rico and the Virgin Islands, and to consumers in a long list of countries starting with Algeria. The label shows a Cheyenne, Wyoming distributor address while the firm files from New York. This is a brand at online-marketplace scale, and every international consumer sale is a separate notification problem.
Who else should care
This is one of at least eight moringa and greens powder Salmonella recalls we count between November 2025 and September 2026. The records do not say they share a supplier, and we do not claim that. What they share is the acceptance step: botanical powder cleared on the supplier’s certificate of analysis rather than a test the buyer ran.
Brands selling single-ingredient botanical capsules at high volume through online channels should read this closely. At a million units, a positive lot is not a small notification exercise. Check: whether you can name the lot of powder behind every bottle you sold, and whether you hold your own Salmonella result for it.
Written 2026-09-08. Analysis is editorial; the record above is FDA's.